H Okada

Summary

Affiliation: Graduate School
Country: Japan

Publications

  1. ncbi A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux
    H Tsugeno
    Dept of Medicine, Misasa Medical Center, Okayama University Medical School, Misasa, Tottori, Japan
    Scand J Gastroenterol 38:456-61. 2003
  2. ncbi C5a inhibitory peptide combined with gabexate mesilate is a clinically available candidate for preventing the instant blood-mediated inflammatory reaction
    K Tokodai
    Division of Advanced Surgical Science and Technology, Tohoku University, Miyaga, Japan
    Transplant Proc 41:67-8. 2009
  3. ncbi C5a-inhibitory peptide combined with gabexate mesilate prevents the instant blood-mediated inflammatory reaction in a rat model of islet transplantation
    K Tokodai
    Division of Advanced Surgical Science and Technology, Tohoku University, Sendai, Japan
    Transplant Proc 42:2102-3. 2010
  4. ncbi Polymorphic expression of decay-accelerating factor in human colorectal cancer
    M Nakagawa
    First Department of Internal Medicine, Okayama University Medical School, Japan
    J Gastroenterol Hepatol 16:184-9. 2001
  5. ncbi A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism
    M Miyoshi
    First Department of Internal Medicine, Okayama University Medical School, Okayama, Japan
    J Gastroenterol Hepatol 16:723-8. 2001
  6. ncbi Clinicopathological features of gastric mucosa associated lymphoid tissue (MALT) lymphomas: high grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features
    T Yoshino
    Department of Pathology, Okayama University Medical School, Japan
    J Clin Pathol 53:187-90. 2000
  7. ncbi Specific gastroduodenoscopic findings in Crohn's disease: Comparison with findings in patients with ulcerative colitis and gastroesophageal reflux disease
    M Kuriyama
    Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1, Shikata cho, Okayama 700 8558, Japan
    Dig Liver Dis 40:468-75. 2008

Collaborators

  • M Goto
  • T Yoshino
  • K Tokodai
  • S Satomi
  • M Kuriyama
  • M Mizuno
  • H Tsugeno
  • J Nasu
  • M Nakagawa
  • T Tsuji
  • M Miyoshi
  • N Okada
  • W Nakanishi
  • A Inagaki
  • N Ogawa
  • T Imura
  • K Fujimori
  • Y Kurokawa
  • J Kato
  • N Morimoto
  • T Fujimoto
  • K Yamamoto
  • S Ashida
  • M Okamoto
  • F Mitsunobu
  • Y Hosaki
  • S Fujiki
  • Y Tanizaki
  • Y Shiratori
  • M Kawada
  • K Ishiki
  • Y Endo
  • Y Nagahara
  • T Torigoe
  • K Yokota
  • T Fujita
  • K Takeuchi
  • T Maga
  • K Oguma
  • T Uesu

Detail Information

Publications7

  1. ncbi A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux
    H Tsugeno
    Dept of Medicine, Misasa Medical Center, Okayama University Medical School, Misasa, Tottori, Japan
    Scand J Gastroenterol 38:456-61. 2003
    ..In this study, we measured ventilatory function in asthma patients treated with a PPI in order to identify those in whom a therapeutic effect on asthma can be expected from the acid suppression...
  2. ncbi C5a inhibitory peptide combined with gabexate mesilate is a clinically available candidate for preventing the instant blood-mediated inflammatory reaction
    K Tokodai
    Division of Advanced Surgical Science and Technology, Tohoku University, Miyaga, Japan
    Transplant Proc 41:67-8. 2009
    ....
  3. ncbi C5a-inhibitory peptide combined with gabexate mesilate prevents the instant blood-mediated inflammatory reaction in a rat model of islet transplantation
    K Tokodai
    Division of Advanced Surgical Science and Technology, Tohoku University, Sendai, Japan
    Transplant Proc 42:2102-3. 2010
    ....
  4. ncbi Polymorphic expression of decay-accelerating factor in human colorectal cancer
    M Nakagawa
    First Department of Internal Medicine, Okayama University Medical School, Japan
    J Gastroenterol Hepatol 16:184-9. 2001
    ..We speculate that this variability could affect the stability of DAF on the surfaces of cancer cells and, in turn, the amount of DAF shed into the stools of colorectal cancer patients...
  5. ncbi A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism
    M Miyoshi
    First Department of Internal Medicine, Okayama University Medical School, Okayama, Japan
    J Gastroenterol Hepatol 16:723-8. 2001
    ..pylori, irrespective of the PPI used (omeprazole or rabeprazole) and CYP2C19 genetic polymorphism. Smoking significantly decreased the cure rate of H. pylori infection in the dual therapy...
  6. ncbi Clinicopathological features of gastric mucosa associated lymphoid tissue (MALT) lymphomas: high grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features
    T Yoshino
    Department of Pathology, Okayama University Medical School, Japan
    J Clin Pathol 53:187-90. 2000
    ....
  7. ncbi Specific gastroduodenoscopic findings in Crohn's disease: Comparison with findings in patients with ulcerative colitis and gastroesophageal reflux disease
    M Kuriyama
    Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1, Shikata cho, Okayama 700 8558, Japan
    Dig Liver Dis 40:468-75. 2008
    ..Crohn's disease patients often carry gastroduodenal lesions. However, few reports have addressed specific gastroduodenoscopic findings in Crohn's disease patients...